Background: The objective of the study was to evaluate the additional value
of beta-glucuronidase (BGD), a lysosomal enzyme in the analysis of transud
ative and exsudative pleural effusions, especially between malignant and no
n-malignant effusions.
Design and methods: Pleural fluid samples obtained from four respective dia
gnostic groups: transudates parapneumonic effusions, malignant effusions or
pleuritis carcinomatosa, and empyema were evaluated.
Results: Beta-glucuronidase was significantly different between transudativ
e and exsudative effusions (p < 0.001) as well as between parapneumonic and
malignant effusions (p < 0.03), parapneumonic effusions and empyema (p < 0
.002), and malignant and empyema (p < 0.002), respectively. Logistic regres
sion analysis yielded a weak discrimination between the parapneumonic and m
alignant groups.
Conclusions: Beta-glucuronidase activity differed between pleural effusions
of various origin. However, including BGD in the biochemical work-up of pl
eural effusions did not reveal discriminatory value in the assessment of th
e classification of these effusions. Copyright (C) 1999 The Canadian Societ
y of Clinical Chemists.